胰岛素基因及其顺式作用元件和反式作用因子

胰岛素基因及其顺式作用元件和反式作用因子杨绍华,陈俊杰（华西医科大学生化与重组ＤＮＡ室,成都６１００４１）关键词胰岛素基因,顺式作用元件,反式作用因子胰岛素基因迄今虽已从多种脊椎动物分离克隆、但对它的研究主要是以鼠和人的基因为对象进行的。除三种鼠（大...     

红系NFE2反式作用因子

ＮＦＥ２是碱性亮氨酸拉链家族成员之一,由一个广泛表达的１８ｋＤ亚基和一个组织限制表达的４５ｋＤ亚基组成。ＮＦＥ２是生血组织特异的反式作用因子。它通过α和β珠蛋白基因簇的位点控制区吝节珠蛋白基因转录。而且对正常血小板的生成是必须的。     

HeLa细胞的反式作用因子CTF／NF—1与其顺式作用元件的特异性作用

本文运用凝胶延迟反应和足迹法研究了ＨｅＬａ细胞核蛋白中的反式作用因子ＣＴＦ／ＮＦ－１与其对应的顺式作用元件的特异性作用。研究结果表明ＨｅＬａ细胞的ＣＴＦ／ＮＦ－１包含有不同分子量的组分,它们均能特异性结合于特异位点ＡＴＡＴＴＧＧＣＴＴＣＡＡＧＣＣＡＡＡＡＴＧＧＡ序列,形成至少５种不同分子量形式的因子－元件复合物,这一结果对阐明ＣＴＦ／ＮＦ－１复杂多样的调控机制及其组成种类有重要意义,此外,本文还建     

β—珠蛋白基因簇表达调控的反式作用因子

β－珠蛋白基因簇是研究真核基因表达调控的良好模型,其基因表达具有红系组织特异性和不同发育阶段特异性,这些特异性的产生依赖于组织特异性表达和发育阶段特异性表达的反式作用因子与顺式作用元件间的相互作用。     

棉花曲叶病毒反式作用因子AC2的功能初探

有关非洲木薯花叶病毒（ACMV）、番茄金色花叶病毒（TGMV）的研究表明,双生病毒编码的反式作用因子AC2反式激活病毒链基因启动子的瞬时表达。以棉花曲叶病毒（CLCuV)侵染的烟草叶片组织总的DNA为模板,通过聚合酶反应扩增CLCuV的AC2基因片段并插入克隆载体。将AC2置于CaMV35S启动子下构建了瞬时表达载体。通过基因他法将质粒载体导入烟草（Nicotiana tabacumL.)和棉花（Gossypium hirstumL.)叶片细胞中进行瞬时表达,结果表明,在反式作用因子AC2的激活下,病毒链基因启动子驱动的GUS活性明显增强,然而激活后的病毒链基因启动子的活性仍低于互补链基因方向启动子;其表达方式与互补链基因启动子相似,即在叶肉及叶脉维管组织均有较高的活性。还探讨了AC2在土壤杆菌介导的转基因植物中的表达行为。     

降血脂药物对酰基CoA氧化酶基因反式作用因子的影响

从对照和用ＤＥＨＰ处理的大鼠肝脏提取核蛋白,以含酰基ＣｏＡ氧化酶基因表达调控部位的ＤＮＡ片段和该基因的不同蛋白结合位点的ＤＮＡ片段作为核蛋白结合反应的探针,通过凝胶电过移率改变实验和Ｓｏｕｔｈｗｅｓｔｅｒｎ印迹分析检查了ＤＥＨＰ对ＡＯＸ基因反式作用因子的含量和（或）与基因的结合活性,在转录水平上促进基因的表达。     

青霉素酰化酶调节基因的定位和反式作用

青霉索酰化酶基因(pac)的定位研究表明它的调节基因和结构基因位于3．5kb的HindI—EcoR I片段。本文报道构建一系列质粒pPA 6的缺失衍生物,并测定这些缺失对pac表达的影响。结果表明调节基因位于pac结构基因内的spb I—Pvu I片段。SphⅠI—PvuⅡ片段克隆到质粒pTzl8u,所得质粒pPA57转化到青霉素酰化酶产生菌E．ColiD816,观察sphⅠ—PvuⅡ片段对染色体pac基因表达的影响。结果表明在sph Ⅰ—PvuⅡ片段内的调节基因反式调节pac基因表达。计算机分析表明在sph Ⅰ—PvuⅡ片段内有两个ORF是编码调节蛋白的可能候选者。Pac调节基因的精确定位正在进行中。     

Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice

The ubiquitin-proteasome system contributes to regulation of apoptosis degrading apoptosis-regulatory proteins. Marked accumulation of ubiquitinated proteins in cardiomyocytes of human failing hearts suggested impaired ubiquitin-proteasome system in heart failure. Since cardiomyocyte apoptosis contributes to the progression of cardiac dysfunction in pressure-overloaded hearts, we investigated the role of ubiquitin-proteasome system in such conditions. We found that proteasome activities already depressed before the onset of cardiac dysfunction in pressure-overloaded hearts of mice. Cardiomyocyte apoptosis was observed along with depression of proteasome activities and elevation of proapoptotic/antiapoptotic protein ratio in failing hearts. In cultured cardiomyocytes, pharmacological inhibition of proteasome accumulated proapoptotic proteins such as p53 and Bax. Gene silencing of these proapoptotic proteins by RNA interference prevented the accumulation of respective proteins and attenuated cardiomyocyte apoptosis induced by proteasome inhibition. We conclude that depression of proteasome activities contributes to cardiac dysfunction resulting from cardiomyocyte apoptosis through accumulation of proapoptotic proteins by impaired degradation.     

人参皂甙Rb1对心力衰竭大鼠蛋白激酶R样内质网激酶途径的影响

目的探讨人参皂甙Rbl（Gs—Rbl）改善阿霉素所致心力衰竭（HF）效应是否与调整蛋白激酶R样内质网激酶（PERK）通路有关。方法阿霉素（Adr）诱导的HF大鼠随机分为HF组（n=15）和Gs．Rbl组（70rng／kg／d,n=17）,另随机选取同龄大鼠作为对照组（n=10）。干预结束并进行心脏超声检查后,TUNNEL检测心肌细胞凋亡率（AR）,Western blot和Rt-PCR检测葡萄糖调节蛋白78（GRP78）、PERK、p-PERK、真核细胞起始因子2-（elF2a）、p-elF2a、C／EBP同源蛋白（CHOP）和cleavedcaspase-12。结果1．Adr干预成功构建HF模型,Gs—Rbl显著提高左室射血分数（LVEF）和降低心肌细胞AR（P〈O．01）;2．HF组GRP78mRNA和蛋白均显著高于对照组,Gs—Rbl显著低于HF组和对照组二组的表达（P〈0．01）;3．Gs—Rbl显著降低HF大鼠PERK和p-PERK表达（P〈0．01）;4．HF导致elF2amRNA和蛋白、p-elF2a显著升高,Gs—Rbl显著下调三者的表达（P〈O．01）;5．HF组CHOPmRNA和蛋白显著高于对照组,Gs—Rbl组显著抑制其表达（P〈0．01）;6．Gs—Rbl显著抑制阿霉素所致的caspase-121TIRNA和cleaved caspase-12蛋白表达（P〈0．01）。结论Gs—Rbl通过调节PERK内质网通路介导其改善HF效应。     

关于回交世代方差中加性×显性分量的讨论A

当两系统存在k对基因差异,P1中增效基因为k-k’对,减效基因k’对时,两纯系杂交回交群体遗传方差加性×显性分量的数学式为F=(k-k’)∑(i=1)d1h1-k’∑(i=1) d1h1.。F的大小决定于显性齐性和基因分散的程度。因此在一般情况下,F的遗传含义是混杂不清的。只有基因完全相联时F=k∑(i=1)d1h1,与Mather 和Jinks 的推导结果一致,这时F反映显性齐性程度。Abstract: Assuming kpairs of different genes between two pure parental lines (P1 and P2), k-k’ pairs of increasing genes and k’ pairs of deereasing genes in P1,the comoponent of additive×dominance in the genetic variance of the backcross generation is represented as F=(k-k’)∑(i=1)d1h1-k’∑(i=1) d1h1.The component F is determined by both the consistency of dominance and the dispersion of genes. In genetral, the genetic implication of the component F is complexity.Only under the situation of complete associates of genes F=k∑(i=1)d1h1,which agrees with the result by Mather and Jinks. In such case, F illustrates the consistency of dominance.     

降血脂药物（DEHP）对酰基CoA氧化酶基因反式作用因子的影响

从对照和用ＤＥＨＰ处理的大鼠肝脏提取核蛋白,以含酰基ＣｏＡ氧化酶（ＡＯＸ）基因表达调控部位的ＤＮＡ片段和该基因的不同蛋白结合位点的ＤＮＡ片段作为核蛋白结合反应的探针,通过凝胶电泳迁移率改变实验和Ｓｏｕｔｈｗｅｓｔｅｒｎ印迹分析检查了ＤＥＨＰ对ＡＯＸ基因反式作用因子的影响。结果表明,降血脂药物ＤＥＨＰ可显著增加ＡＯＸ基因反式作用因子的含量和（或）与基因的结合活性,在转录水平上促进基因的表达。     

AFFINITY LABELING OF CYSTEINE-MUTANTS EVIDENCES CONTACT RESIDUES IN MODELED RECEPTOR BINDING SITES

ABSTRACT

To investigate the topology of binding sites in two ionotropic receptors, we have initiated a strategy combining affinity labeling with cysteine-scanning mutagenesis. For the GABA_A receptor we have used reactive derivatives of non-competitive blockers (NCBs) to explore interacting positions in its channel. The polypeptide positions of the M₂ segment of the α₁ subunit which we mutated into cysteine were selected for their established accessibility, as determined by the substituted-cysteine accessibility method (SCAM). Using the Xenopus oocyte expression system, we show that receptors containing mutations V257C and S272C are inactivated by several reactive NCBs. These position-selective inactivations lead to an analysis of NCB binding in the channel. For the NMDA receptor glycine-binding site, the prototype antagonist L-701,324 was derivatized at different positions with different reactive groups. The receptor positions to mutate into cysteine were selected after a 3-D homology model. The observed receptor inactivations are mutant- and probe-selective, leading to an unambiguous chemical docking of the antagonist pharmacophore and supporting the model. The site-specificity of the inactivating reactions is assessed by protection experiments and by mutant to wild-type (WT) comparisons. The scope and limitations of the method are briefly discussed.     

The role of protein kinase C-mediated phosphorylation of sarcomeric proteins in the heart—detrimental or beneficial?

Protein kinase C (PKC) is a family of serine/threonine protein kinases, and alterations have been found in PKC isoform expression and localization in the failing heart. These alterations in PKC activation levels influence the PKC-mediated phosphorylation status of cellular target proteins involved in Ca²⁺-handling and sarcomeric contraction. The differences observed in the effects due to PKC-mediated phosphorylation may underlie part of the contractile dysfunction observed in the failing heart. It is therefore important to establish the beneficial and detrimental effects of this kinase in the healthy and failing heart. The function of PKC has been studied intensively; however, the complexity of the regulation of this kinase makes the interpretation of the different effects difficult. The main focus of this review is the (patho)physiological impact of phosphorylation of sarcomeric proteins, myosin light chain-2, troponin I and T, desmin, myosin binding protein-C, and titin by PKC.     

Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyroxine

Thyroxine can cause cardiac hypertrophy by activating growth factors, such as IGF-I (insulin-like growth factor-I). Since oxidative stress is enhanced in the hyperthyroidism, it would control protein expression involved in this hypertrophy. Male Wistar rats were divided into four groups: (I) control, (II) vitamin E-supplemented (20 mg/kg/day subcutaneous), (III) hyperthyroid (thyroxine 12 mg/l, in drinking water), and (IV) hyperthyroid + vitamin E. After 4 weeks, the contractility and relaxation indexes of left ventricle (LV), and cardiac mass were increased by 54%, 60%, and 60%, respectively, in hyperthyroid group. An increase in lipid peroxidation (around 40%), and a decrease in total glutathione (by 20%) was induced by thyroxine and avoided by vitamin E administration. Superoxide dismutase (SOD) and glutathione-S-transferase (GST) activities were increased (by 83% and 54%, respectively) in hyperthyroid, and vitamin E avoided changes in SOD. Protein expression of SOD, GST, and IGF-I receptor (IGF-IR) were increased (by 87%, 84%, and 60%, respectively) by thyroxine, and vitamin E promoted a significant reduction in SOD and IGF-IR expression (by 36% and 17%, respectively). These results indicate that oxidative stress is involved in cardiac hypertrophy, and suggest a role for IGF-IR as a mediator of this adaptive response in experimental hyperthyroidism.     

LPS regulate ERK1/2-dependent signaling in cardiac fibroblasts via PKC-mediated MKP-1 induction

Activation of MAPK pathways by angiotensin II (Ang II) is important for cardiac fibroblast (CFB) proliferation and migration. Activity of MAP-kinases is closely controlled by a group of dual-specific MAP kinase phosphatases (MKPs). Lipopolysaccharides (LPS) and cytokines are elevated in patients with heart failure and may contribute to disease progression. In this study, we investigate the effect of LPS on Ang II-induced CFB function. Pretreatment of CFBs with LPS (1 microg/mL; 30 min) almost completely inhibited Ang II-induced DNA-synthesis and inhibited Ang II directed chemotaxis by more than 80%. Compared to controls, LPS pretreatment significantly reduced phosphorylation levels of ERK1/2- and p38 MAPK and induced MKP-1 levels. Silencing MKP-1 with antisense oligodesoxynucleotides reversed the antimitogenic effect of LPS on Ang II-induced CFB DNA-synthesis and migration. Induction of MKP-1 by LPS was inhibited by the protein kinase C (PKC)-inhibitor calphostin C, but not by the ERK1/2-pathway inhibitor PD98059, suggesting that PKC but not ERK1/2 is required for LPS-mediated MKP-1 induction in CFBs. Our data demonstrate that LPS have direct cellular effects in CFBs through an inhibition of Ang II-induced MAPK activity via PKC-mediated induction of MKP-1. This might be relevant with regard to the decreased MAPK activity and increased levels in MKPs reported during chronic heart failure in humans.